Concepts (125)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hearing Loss | 4 | 2017 | 46 | 0.640 |
Why?
|
| Deafness | 3 | 2017 | 33 | 0.630 |
Why?
|
| Salivary Gland Neoplasms | 1 | 2017 | 9 | 0.570 |
Why?
|
| Spiral Ganglion | 2 | 2017 | 11 | 0.550 |
Why?
|
| Cochlear Implants | 2 | 2017 | 30 | 0.530 |
Why?
|
| Cochlear Implantation | 2 | 2017 | 26 | 0.430 |
Why?
|
| Physicians | 2 | 2009 | 441 | 0.430 |
Why?
|
| Correction of Hearing Impairment | 1 | 2012 | 2 | 0.410 |
Why?
|
| Persons With Hearing Impairments | 1 | 2012 | 25 | 0.390 |
Why?
|
| DNA Mutational Analysis | 1 | 2012 | 196 | 0.390 |
Why?
|
| Sentinel Lymph Node Biopsy | 1 | 2012 | 40 | 0.390 |
Why?
|
| Usher Syndromes | 1 | 2011 | 4 | 0.390 |
Why?
|
| Otorhinolaryngologic Neoplasms | 1 | 2011 | 5 | 0.380 |
Why?
|
| Leiomyosarcoma | 1 | 2011 | 9 | 0.380 |
Why?
|
| Meniere Disease | 1 | 2011 | 13 | 0.380 |
Why?
|
| Skin Neoplasms | 2 | 2012 | 405 | 0.340 |
Why?
|
| Bandages | 1 | 2010 | 15 | 0.340 |
Why?
|
| Thromboembolism | 1 | 2010 | 70 | 0.330 |
Why?
|
| Heparin | 1 | 2010 | 111 | 0.320 |
Why?
|
| Pancreatectomy | 1 | 2009 | 93 | 0.310 |
Why?
|
| Surgical Procedures, Operative | 1 | 2010 | 139 | 0.300 |
Why?
|
| Melanoma | 1 | 2012 | 334 | 0.300 |
Why?
|
| Hepatectomy | 1 | 2008 | 59 | 0.300 |
Why?
|
| Cause of Death | 1 | 2009 | 205 | 0.300 |
Why?
|
| Hemorrhage | 1 | 2010 | 272 | 0.290 |
Why?
|
| Mutation | 2 | 2012 | 2464 | 0.280 |
Why?
|
| Liver Diseases | 1 | 2008 | 136 | 0.280 |
Why?
|
| Wounds and Injuries | 1 | 2010 | 243 | 0.280 |
Why?
|
| Hearing | 2 | 2017 | 29 | 0.260 |
Why?
|
| Pancreatic Neoplasms | 1 | 2009 | 326 | 0.250 |
Why?
|
| General Surgery | 1 | 2008 | 193 | 0.250 |
Why?
|
| Anticoagulants | 1 | 2010 | 487 | 0.250 |
Why?
|
| Hospitals | 1 | 2008 | 376 | 0.250 |
Why?
|
| Phenotype | 4 | 2013 | 1157 | 0.250 |
Why?
|
| Radiotherapy, Adjuvant | 2 | 2017 | 61 | 0.230 |
Why?
|
| Audiometry, Pure-Tone | 2 | 2015 | 23 | 0.230 |
Why?
|
| Auditory Threshold | 2 | 2015 | 24 | 0.230 |
Why?
|
| Hospital Mortality | 1 | 2009 | 851 | 0.230 |
Why?
|
| Clinical Competence | 1 | 2009 | 698 | 0.220 |
Why?
|
| Aged | 7 | 2017 | 13553 | 0.220 |
Why?
|
| Genetic Testing | 3 | 2013 | 132 | 0.210 |
Why?
|
| Neoplasm Staging | 2 | 2017 | 458 | 0.210 |
Why?
|
| Genetic Variation | 3 | 2017 | 367 | 0.210 |
Why?
|
| Postoperative Complications | 1 | 2010 | 1169 | 0.210 |
Why?
|
| Middle Aged | 8 | 2017 | 16500 | 0.200 |
Why?
|
| Male | 10 | 2017 | 27914 | 0.180 |
Why?
|
| Software | 2 | 2015 | 373 | 0.180 |
Why?
|
| Retrospective Studies | 5 | 2017 | 6125 | 0.180 |
Why?
|
| Female | 10 | 2017 | 31191 | 0.170 |
Why?
|
| Humans | 15 | 2017 | 60049 | 0.160 |
Why?
|
| Survival Rate | 2 | 2012 | 793 | 0.150 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2012 | 678 | 0.150 |
Why?
|
| Salivary Ducts | 1 | 2017 | 1 | 0.140 |
Why?
|
| Carcinoma, Mucoepidermoid | 1 | 2017 | 6 | 0.140 |
Why?
|
| Adenoma, Pleomorphic | 1 | 2017 | 8 | 0.140 |
Why?
|
| Neoplasm Grading | 1 | 2017 | 75 | 0.140 |
Why?
|
| Serine Endopeptidases | 2 | 2017 | 82 | 0.130 |
Why?
|
| Connexin 26 | 2 | 2014 | 2 | 0.130 |
Why?
|
| Survival Analysis | 1 | 2017 | 557 | 0.130 |
Why?
|
| Connexins | 2 | 2014 | 10 | 0.130 |
Why?
|
| Acoustic Stimulation | 2 | 2012 | 50 | 0.120 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2015 | 46 | 0.120 |
Why?
|
| Treatment Outcome | 3 | 2017 | 5258 | 0.120 |
Why?
|
| Neoplasm Proteins | 2 | 2017 | 277 | 0.120 |
Why?
|
| Aged, 80 and over | 2 | 2017 | 5181 | 0.120 |
Why?
|
| Genomics | 2 | 2017 | 314 | 0.120 |
Why?
|
| Exome | 1 | 2014 | 73 | 0.120 |
Why?
|
| Adenocarcinoma | 1 | 2017 | 327 | 0.110 |
Why?
|
| Genome, Human | 2 | 2014 | 219 | 0.110 |
Why?
|
| Genotype | 2 | 2013 | 643 | 0.100 |
Why?
|
| Adult | 5 | 2017 | 15949 | 0.100 |
Why?
|
| Evolution, Molecular | 1 | 2014 | 294 | 0.100 |
Why?
|
| Genes, Modifier | 1 | 2011 | 3 | 0.100 |
Why?
|
| Genetic Linkage | 1 | 2011 | 101 | 0.090 |
Why?
|
| Chi-Square Distribution | 1 | 2012 | 405 | 0.090 |
Why?
|
| Adolescent | 3 | 2017 | 5949 | 0.090 |
Why?
|
| Lymphatic Metastasis | 1 | 2011 | 70 | 0.090 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2011 | 31 | 0.090 |
Why?
|
| Analysis of Variance | 1 | 2012 | 577 | 0.090 |
Why?
|
| Membrane Proteins | 2 | 2017 | 844 | 0.090 |
Why?
|
| Polymorphism, Genetic | 1 | 2011 | 194 | 0.090 |
Why?
|
| Neoplasm Invasiveness | 1 | 2011 | 248 | 0.090 |
Why?
|
| Combined Modality Therapy | 1 | 2011 | 360 | 0.090 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2011 | 391 | 0.090 |
Why?
|
| Population Surveillance | 1 | 2011 | 206 | 0.090 |
Why?
|
| Case-Control Studies | 2 | 2014 | 1063 | 0.090 |
Why?
|
| Patient Selection | 1 | 2012 | 453 | 0.080 |
Why?
|
| Vestibular Function Tests | 1 | 2009 | 4 | 0.080 |
Why?
|
| Evoked Potentials, Auditory | 1 | 2009 | 10 | 0.080 |
Why?
|
| Semicircular Canals | 1 | 2009 | 11 | 0.080 |
Why?
|
| Vestibular Diseases | 1 | 2009 | 9 | 0.080 |
Why?
|
| Probability | 1 | 2009 | 173 | 0.080 |
Why?
|
| Confidence Intervals | 1 | 2009 | 257 | 0.080 |
Why?
|
| Health Care Surveys | 1 | 2009 | 281 | 0.070 |
Why?
|
| Registries | 1 | 2011 | 805 | 0.070 |
Why?
|
| Carrier Proteins | 1 | 2012 | 710 | 0.070 |
Why?
|
| Child | 1 | 2017 | 4328 | 0.070 |
Why?
|
| Severity of Illness Index | 1 | 2012 | 1471 | 0.070 |
Why?
|
| Age Factors | 1 | 2011 | 1524 | 0.070 |
Why?
|
| Young Adult | 1 | 2017 | 4384 | 0.070 |
Why?
|
| Prognosis | 1 | 2011 | 1589 | 0.070 |
Why?
|
| Odds Ratio | 1 | 2009 | 774 | 0.070 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 1541 | 0.060 |
Why?
|
| Logistic Models | 1 | 2009 | 1255 | 0.060 |
Why?
|
| Audiometry | 2 | 2017 | 17 | 0.060 |
Why?
|
| Reproducibility of Results | 2 | 2013 | 1565 | 0.040 |
Why?
|
| Cochlea | 1 | 2017 | 22 | 0.030 |
Why?
|
| Models, Neurological | 1 | 2017 | 81 | 0.030 |
Why?
|
| Speech Perception | 1 | 2017 | 79 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2014 | 129 | 0.030 |
Why?
|
| Phylogeny | 1 | 2014 | 334 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2014 | 324 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2013 | 397 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2013 | 454 | 0.020 |
Why?
|
| Reflex, Vestibulo-Ocular | 1 | 2009 | 2 | 0.020 |
Why?
|
| Neck Muscles | 1 | 2009 | 9 | 0.020 |
Why?
|
| Bone Conduction | 1 | 2009 | 6 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2009 | 125 | 0.020 |
Why?
|
| Internet | 1 | 2013 | 463 | 0.020 |
Why?
|
| Electromyography | 1 | 2009 | 87 | 0.020 |
Why?
|
| Syndrome | 1 | 2009 | 173 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2009 | 209 | 0.020 |
Why?
|
| ROC Curve | 1 | 2009 | 259 | 0.020 |
Why?
|
| Muscle Contraction | 1 | 2009 | 199 | 0.020 |
Why?
|
| Algorithms | 1 | 2013 | 1001 | 0.020 |
Why?
|